SCHEMBL8484256

SCHEMBL8484256

c1cc(Nc2ncnc3cnc(N4CCOCC4)nc23)c2ccncc2c1

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRAF P15056 19/20 0.51
TRPV1 Q8NER1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8486442 0.85 BRAF (0.52) BRAF
SCHEMBL8489738 0.85 BRAF (0.54) BRAF
SCHEMBL8487253 0.81 BRAF (0.53) BRAF
SCHEMBL8487628 0.81 BRAF (0.55) BRAF
SCHEMBL8486738 0.79 BRAF (0.52) BRAF
SCHEMBL8485805 0.79 BRAF (0.50) BRAF
SCHEMBL8314586 0.78 BRAF (0.55) BRAF
SCHEMBL8316477 0.78 BRAF (0.64) BRAF
SCHEMBL8483815 0.77 BRAF (0.54) BRAF
SCHEMBL8488606 0.75 BRAF (0.52) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977102-A INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES OR EPIDERMAL GROWTH FACTOR; ANTITUMOR,-CARCINOGENIC, -METASTASIS,-PROLIFERATION AGENTS AND -INFLAMMATORY AGENTS; PSORIASIS; ANGIOGENESIS INHIBITORS; IMMUNOLOGY; DR. KARL THOMAE GMBH (DE) 1999-11-02 US disclosed